ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹3.39 Cr | ₹3.63 Cr | ₹13 Cr | ₹11 Cr | ₹12 Cr |
What is the latest Long Term Provisions ratio of ORCHID PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹3.39 Cr |
| Mar2024 | ₹3.63 Cr |
| Mar2023 | ₹13 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹12 Cr |
How is Long Term Provisions of ORCHID PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.39 Cr | -6.80 | |
| Mar2024 | ₹3.63 Cr | -71.16 | |
| Mar2023 | ₹13 Cr | 14.43 | |
| Mar2022 | ₹11 Cr | -4.56 | |
| Mar2021 | ₹12 Cr | - | |
Compare Long Term Provisions of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹6,081.3 Cr | 6.3% | -4.4% | 43.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,236.0 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,673.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,460.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,220.3 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 6.3% |
-4.4% |
43.3% |
| SENSEX | -1.6% |
-4.2% |
-7.2% |
You may also like the below Video Courses